Antonio Rossi Selected Research

Antonio Rossi Research Topics

Disease

115	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 03/2003
57	Neoplasms (Cancer) 05/2022 - 09/2003
28	Lung Neoplasms (Lung Cancer) 05/2022 - 03/2003
17	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 06/2002
11	Disease Progression 05/2022 - 06/2007
11	Diastrophic dysplasia 01/2021 - 07/2003
10	Infections 04/2022 - 12/2006
10	Osteogenesis Imperfecta (Lobstein Disease) 01/2021 - 06/2007
8	COVID-19 04/2022 - 12/2020
8	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2002
7	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2003
7	Vomiting 01/2019 - 01/2002
7	Prolidase Deficiency 03/2015 - 09/2003
6	Type 2 Diabetes Mellitus (MODY) 05/2022 - 08/2016
5	Mycoses (Diseases, Fungus) 06/2021 - 11/2008
5	Adenocarcinoma 01/2021 - 05/2010
5	Nausea 01/2019 - 01/2002
4	Desbuquois syndrome 08/2021 - 10/2010
4	Carcinogenesis 01/2013 - 09/2003
4	Breast Neoplasms (Breast Cancer) 12/2008 - 03/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 01/2022
3	Adenocarcinoma of Lung 04/2017 - 05/2005
3	Congenital Abnormalities (Deformity) 01/2017 - 07/2010
3	Diarrhea 08/2013 - 01/2002
3	Omani type Spondyloepiphyseal dysplasia 08/2012 - 06/2008
3	Neutropenia 10/2009 - 01/2002
2	Intellectual Disability (Idiocy) 10/2022 - 12/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 01/2003
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 07/2020
2	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2017
2	Weight Loss (Weight Reduction) 01/2021 - 06/2007
2	Insulin Resistance 01/2021 - 07/2020
2	Carcinoid Tumor (Carcinoid) 01/2021 - 05/2019
2	Obesity 07/2020 - 05/2007

Drug/Important Bio-Agent (IBA)

27	ErbB Receptors (EGF Receptor)IBA 02/2022 - 05/2004
18	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2017 - 01/2007
17	Tyrosine Kinase InhibitorsIBA 02/2022 - 05/2004
15	PlatinumIBA 01/2017 - 11/2005
13	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2004
13	Pharmaceutical PreparationsIBA 02/2021 - 04/2007
13	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2003
11	Biological ProductsIBA 01/2022 - 09/2003
11	Monoclonal AntibodiesIBA 11/2020 - 01/2004
10	Bevacizumab (Avastin)FDA Link 01/2020 - 10/2007
10	Gefitinib (Iressa)FDA Link 12/2017 - 05/2004
8	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 05/2016
8	EnzymesIBA 01/2020 - 08/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2007
8	Cetuximab (Erbitux)FDA Link 06/2018 - 08/2006
8	Pemetrexed (MTA)FDA Link 01/2017 - 03/2007
8	Gemcitabine FDA Link 03/2014 - 03/2007
7	Collagen Type I (Type I Collagen)IBA 01/2021 - 07/2009
7	CollagenIBA 01/2021 - 06/2006
7	Sulfates (Sulfates, Inorganic)IBA 01/2021 - 07/2003
7	proline dipeptidase (prolidase)IBA 03/2015 - 06/2005
6	Immune Checkpoint InhibitorsIBA 12/2021 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 07/2021 - 09/2011
6	Sulfate TransportersIBA 05/2014 - 07/2003
5	VaccinesIBA 04/2022 - 09/2009
5	Anaplastic Lymphoma KinaseIBA 11/2020 - 03/2013
5	pembrolizumabIBA 01/2020 - 01/2016
5	Fluorouracil (Carac)FDA LinkGeneric 05/2003 - 01/2002
4	CytokinesIBA 01/2022 - 05/2007
4	GlycosaminoglycansIBA 08/2021 - 01/2017
4	Proteasome InhibitorsIBA 02/2021 - 05/2014
3	Proteoglycans (Proteoglycan)IBA 10/2022 - 07/2010
3	Insulin (Novolin)FDA Link 07/2022 - 12/2020
3	osimertinibIBA 05/2022 - 12/2017
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 06/2005
3	Bortezomib (Velcade)FDA Link 02/2021 - 05/2014
3	ChloridesIBA 01/2021 - 07/2003
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 10/2015
3	Liraglutide FDA Link 01/2021 - 08/2016
3	Keratins (Keratin)IBA 01/2020 - 07/2009
3	Angiogenesis InhibitorsIBA 01/2019 - 10/2007
3	SulfotransferasesIBA 01/2019 - 10/2010
3	LigandsIBA 01/2018 - 12/2014
3	AfatinibIBA 12/2017 - 08/2013
3	Docetaxel (Taxotere)FDA Link 04/2017 - 01/2011
3	Phosphotransferases (Kinase)IBA 01/2013 - 02/2007
3	Phosphates (Orthophosphate)IBA 10/2008 - 04/2007
3	Vinorelbine (Navelbine)FDA LinkGeneric 03/2003 - 06/2002
3	Leucovorin (Folinic Acid)FDA Link 03/2003 - 01/2002
2	Antiviral Agents (Antivirals)IBA 04/2022 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2013
2	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 05/2016
2	Messenger RNA (mRNA)IBA 02/2021 - 05/2019
2	Peptides (Polypeptides)IBA 01/2021 - 07/2013
2	NucleotidesIBA 01/2021 - 06/2015
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 07/2009
2	Oxygen (Dioxygen)IBA 12/2020 - 06/2009

Therapy/Procedure

56	Drug Therapy (Chemotherapy) 12/2019 - 01/2003
51	Therapeutics 04/2022 - 09/2003
13	Immunotherapy 07/2021 - 12/2014
5	Radiotherapy 12/2021 - 05/2005
4	Adjuvant Chemotherapy 07/2011 - 01/2007
2	Renal Dialysis (Hemodialysis) 08/2021 - 02/2008
2	Precision Medicine 01/2021 - 05/2014
2	Injections 01/2021 - 07/2013